User talk:PharmDrafts
Editor talk page·2 messages
I think we disagree about Active pharmaceutical ingredient
We have now reverted each other twice on Active pharmaceutical ingredient, which is a sign that the disagreement is substantive rather than accidental. My reading is that the source supports the weaker of the two claims. Rather than continue in edit summaries, shall we put it on the article talk page and let someone else weigh in? — LabelLibby (talk) 13:47, 3 January 2026 (UTC)
Thank you for the note. I have proposed a wording that states the weaker claim and attributes the stronger one, which may satisfy both. — PharmDrafts (talk) 12:07, 4 January 2026 (UTC)
Guidance date in Research use only
The guidance cited in Research use only has no date, and it has been revised at least once since the version the article describes. Adding the year would make it clear which version the sentence refers to. — StudentSindhu (talk) 23:30, 30 January 2026 (UTC)
Added. The article was describing the superseded version, which I have now said explicitly. — PharmDrafts (talk) 16:50, 31 January 2026 (UTC)